Loading organizations...
Qianhai Shenghui Investment operates as an equity investment fund, deploying capital into growth-stage enterprises across China. The firm specializes in strategic private equity placements, targeting companies poised for advancement in high-tech and emerging industries. Its investment strategy emphasizes thorough due diligence and participation in financing rounds, notably in biotechnology and advanced pharmaceuticals.
Shenzhen Qianhai Shenghui Investment Fund Partnership (Limited Partnership) emerged from Qianhai's dynamic financial ecosystem. While specific founders are not publicly detailed, its formation aligns with regional efforts to cultivate innovative ventures. The fund's earliest public investment activity dates to at least 2018, demonstrating its role backing developing companies.
Qianhai Shenghui Investment partners with portfolio companies, providing capital to fuel their expansion and innovation. The firm's long-term vision centers on fostering strategic industries within China by enabling transformative companies to achieve objectives, seeking significant returns through their successful growth.
Qianhai Shenghui Investment has 1 tracked investment across 1 company. The latest tracked deal is $25.0M Series C in Sirnaomics in June 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 6, 2018 | Sirnaomics | $25.0M Series C | — | Huakong Equity Investment, Sangel Capital |